keyword
MENU ▼
Read by QxMD icon Read
search

dimethyltryptamine

keyword
https://www.readbyqxmd.com/read/27900674/serotonergic-hallucinogen-induced-visual-perceptual-alterations
#1
Michael Kometer, Franz X Vollenweider
Serotonergic hallucinogens, such as lysergic acid diethylamide (LSD), psilocybin, and N,N-dimethyltryptamine (DMT), are famous for their capacity to temporally and profoundly alter an individual's visual experiences. These visual alterations show consistent attributes despite large inter- and intra-individual variances. Many reports document a common perception of colors as more saturated, with increased brightness and contrast in the environment ("Visual Intensifications"). Environmental objects might be altered in size ("Visual illusions") or take on a modified and special meaning for the subject ("Altered self-reference")...
November 30, 2016: Current Topics in Behavioral Neurosciences
https://www.readbyqxmd.com/read/27896660/ayahuasca-exposure-descriptive-analysis-of-calls-to-us-poison-control-centers-from-2005-to-2015
#2
C William Heise, Daniel E Brooks
BACKGROUND: Ayahuasca is a hallucinogenic plant preparation which usually contains the vine Banisteriopsis caapi and the shrub Psychotria viridis. This tea originates from the Amazon Basin where it is used in religious ceremonies. Because interest in these religious groups spreading as well as awareness of use of ayahuasca for therapeutic and recreational purposes, its use is increasing. Banisteriopsis caapi is rich in β-carbolines, especially harmine, tetrahydroharmine and harmaline, which have monoamine oxidase inhibiting (MAOI) activity...
November 28, 2016: Journal of Medical Toxicology: Official Journal of the American College of Medical Toxicology
https://www.readbyqxmd.com/read/27709018/development-of-a-mechanism-based-pharmacokinetic-pharmacodynamic-model-to-characterize-the-thermoregulatory-effects-of-serotonergic-drugs-in-mice
#3
Xi-Ling Jiang, Hong-Wu Shen, Donald E Mager, Stephan Schmidt, Ai-Ming Yu
We have shown recently that concurrent harmaline, a monoamine oxidase-A inhibitor (MAOI), potentiates serotonin (5-HT) receptor agonist 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT)-induced hyperthermia. The objective of this study was to develop an integrated pharmacokinetic/pharmacodynamic (PK/PD) model to characterize and predict the thermoregulatory effects of such serotonergic drugs in mice. Physiological thermoregulation was described by a mechanism-based indirect-response model with adaptive feedback control...
September 2016: Acta Pharmaceutica Sinica. B
https://www.readbyqxmd.com/read/27683542/the-endogenous-hallucinogen-and-trace-amine-n-n-dimethyltryptamine-dmt-displays-potent-protective-effects-against-hypoxia-via-sigma-1-receptor-activation-in-human-primary-ipsc-derived-cortical-neurons-and-microglia-like-immune-cells
#4
Attila Szabo, Attila Kovacs, Jordi Riba, Srdjan Djurovic, Eva Rajnavolgyi, Ede Frecska
N,N-dimethyltryptamine (DMT) is a potent endogenous hallucinogen present in the brain of humans and other mammals. Despite extensive research, its physiological role remains largely unknown. Recently, DMT has been found to activate the sigma-1 receptor (Sig-1R), an intracellular chaperone fulfilling an interface role between the endoplasmic reticulum (ER) and mitochondria. It ensures the correct transmission of ER stress into the nucleus resulting in the enhanced production of antistress and antioxidant proteins...
2016: Frontiers in Neuroscience
https://www.readbyqxmd.com/read/27471468/a-model-for-the-application-of-target-controlled-intravenous-infusion-for-a-prolonged-immersive-dmt-psychedelic-experience
#5
Andrew R Gallimore, Rick J Strassman
The state of consciousness induced by N,N-dimethyltryptamine (DMT) is one of the most extraordinary of any naturally-occurring psychedelic substance. Users consistently report the complete replacement of normal subjective experience with a novel "alternate universe," often densely populated with a variety of strange objects and other highly complex visual content, including what appear to be sentient "beings." The phenomenology of the DMT state is of great interest to psychology and calls for rigorous academic enquiry...
2016: Frontiers in Pharmacology
https://www.readbyqxmd.com/read/27470427/measuring-the-subjective-revisiting-the-psychometric-properties-of-three-rating-scales-that-assess-the-acute-effects-of-hallucinogens
#6
José Carlos Bouso, Eduardo José Pedrero-Pérez, Sam Gandy, Miguel Ángel Alcázar-Córcoles
OBJECTIVE: In the present study we explored the psychometric properties of three widely used questionnaires to assess the subjective effects of hallucinogens: the Hallucinogen Rating Scale (HRS), the Mystical Experience Questionnaire (MEQ), and the Addiction Research Center Inventory (ARCI). METHODS: These three questionnaires were administered to a sample of 158 subjects (100 men) after taking ayahuasca, a hallucinogen whose main active component is N,N-dimethyltryptamine (DMT)...
September 2016: Human Psychopharmacology
https://www.readbyqxmd.com/read/27435062/ayahuasca-enhances-creative-divergent-thinking-while-decreasing-conventional-convergent-thinking
#7
K P C Kuypers, J Riba, M de la Fuente Revenga, S Barker, E L Theunissen, J G Ramaekers
INTRODUCTION: Ayahuasca is a South American psychotropic plant tea traditionally used in Amazonian shamanism. The tea contains the psychedelic 5-HT2A receptor agonist N,N-dimethyltryptamine (DMT), plus β-carboline alkaloids with monoamine oxidase-inhibiting properties. Increasing evidence from anecdotal reports and open-label studies indicates that ayahuasca may have therapeutic effects in treatment of substance use disorders and depression. A recent study on the psychological effects of ayahuasca found that the tea reduces judgmental processing and inner reactivity, classic goals of mindfulness psychotherapy...
September 2016: Psychopharmacology
https://www.readbyqxmd.com/read/27390204/-the-potential-use-of-ayahuasca-in-psychiatry
#8
Ede Frecska, Petra Bokor, Gabor Andrassy, Attila Kovacs
Ayahuasca is a decoctum made of admixture plants containing dimethyltryptamine and harmine. For millennia it has been used as a central element of spiritual, religious, initiation, and other - foremost healing - rituals, originally by the indigenous groups of the Amazon basin and later by the mestizo populations of the region. During the last two decades the brew has raised increased scientific and lay interest about its healing potentials within the framework of Western therapeutic settings. The typical ayahuasca effects consist of strong somatic reactions, vivid visions, relived personal memories, cathartic emotions, and insightful, introspective experiences when the emerging mental contents take different context and get deeper perspectives...
June 2016: Neuropsychopharmacologia Hungarica
https://www.readbyqxmd.com/read/27348465/application-of-ambient-ionization-high-resolution-mass-spectrometry-to-determination-of-the-botanical-provenance-of-the-constituents-of-psychoactive-drug-mixtures
#9
Ashton D Lesiak, Rabi A Musah
A continuing challenge in analytical chemistry is species-level determination of the constituents of mixtures that are made of a combination of plant species. There is an added urgency to identify components in botanical mixtures that have mind altering properties, due to the increasing global abuse of combinations of such plants. Here we demonstrate the proof of principle that ambient ionization mass spectrometry, namely direct analysis in real time-high resolution mass spectrometry (DART-HRMS), and statistical analysis tools can be used to rapidly determine the individual components within a psychoactive brew (Ayahuasca) made from a mixture of botanicals...
September 2016: Forensic Science International
https://www.readbyqxmd.com/read/27320963/what-is-the-contribution-of-human-fmo3-in-the-n-oxygenation-of-selected-therapeutic-drugs-and-drugs-of-abuse
#10
Lea Wagmann, Markus R Meyer, Hans H Maurer
Little is known about the role of flavin-containing monooxygenases (FMOs) in the metabolism of xenobiotics. FMO3 is the isoform in adult human liver with the highest impact on drug metabolism. The aim of the presented study was to elucidate the contribution of human FMO3 to the N-oxygenation of selected therapeutic drugs and drugs of abuse (DOAs). Its contribution to the in vivo hepatic net clearance of the N-oxygenation products was calculated by application of an extended relative activity factor (RAF) approach to differentiate from contribution of cytochrome P450 (CYP) isoforms...
September 6, 2016: Toxicology Letters
https://www.readbyqxmd.com/read/27230395/effects-of-ayahuasca-and-its-alkaloids-on-drug-dependence-a-systematic-literature-review-of-quantitative-studies-in-animals-and-humans
#11
Amanda A Nunes, Rafael G Dos Santos, Flávia L Osório, Rafael F Sanches, José Alexandre S Crippa, Jaime E C Hallak
Recently, the anti-addictive potential of ayahuasca, a dimethyltryptamine(DMT)- and β-carboline-rich hallucinogenic beverage traditionally used by indigenous groups of the Northwest Amazon and currently by syncretic churches worldwide, has received increased attention. To better evaluate this topic, we performed a systematic literature review using the PubMed database to find quantitative studies (using statistical analysis) that assessed the effects of ayahuasca or its components in drug-related symptoms or disorders...
July 2016: Journal of Psychoactive Drugs
https://www.readbyqxmd.com/read/27216487/receptor-interaction-profiles-of-novel-psychoactive-tryptamines-compared-with-classic-hallucinogens
#12
Anna Rickli, Olivier D Moning, Marius C Hoener, Matthias E Liechti
The present study investigated interactions between the novel psychoactive tryptamines DiPT, 4-OH-DiPT, 4-OH-MET, 5-MeO-AMT, and 5-MeO-MiPT at monoamine receptors and transporters compared with the classic hallucinogens lysergic acid diethylamide (LSD), psilocin, N,N-dimethyltryptamine (DMT), and mescaline. We investigated binding affinities at human monoamine receptors and determined functional serotonin (5-hydroxytryptamine [5-HT]) 5-HT2A and 5-HT2B receptor activation. Binding at and the inhibition of human monoamine uptake transporters and transporter-mediated monoamine release were also determined...
August 2016: European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology
https://www.readbyqxmd.com/read/27160185/sigma-1-receptors-modulate-neonatal-nav1-5-ion-channels-in-breast-cancer-cell-lines
#13
Ebru Aydar, Dan Stratton, Scott P Fraser, Mustafa B A Djamgoz, Christopher Palmer
The main aim of this study was to investigate a possible functional connection between sigma-1 receptors and voltage-gated sodium channels (VGSCs) in human breast cancer cells. The hypothesis was that sigma-1 drugs could alter the metastatic properties of breast cancer cells via the VGSC. Evidence was found for expression of sigma-1 receptor and neonatal Nav1.5 (nNav1.5) expression in both MDA-MB-231 and MDA-MB-468 cells. Sigma-1 drugs (SKF10047 and dimethyltryptamine) did not affect cell proliferation or migration but significantly reduced adhesion to the substrate...
May 9, 2016: European Biophysics Journal: EBJ
https://www.readbyqxmd.com/read/27127466/dimethyltryptamine-dmt-a-biochemical-swiss-army-knife-in-neuroinflammation-and-neuroprotection
#14
Attila Szabo, Ede Frecska
No abstract text is available yet for this article.
March 2016: Neural Regeneration Research
https://www.readbyqxmd.com/read/27126737/neuropharmacology-of-n-n-dimethyltryptamine
#15
REVIEW
Theresa M Carbonaro, Michael B Gatch
N,N-dimethyltryptamine (DMT) is an indole alkaloid widely found in plants and animals. It is best known for producing brief and intense psychedelic effects when ingested. Increasing evidence suggests that endogenous DMT plays important roles for a number of processes in the periphery and central nervous system, and may act as a neurotransmitter. This paper reviews the current literature of both the recreational use of DMT and its potential roles as an endogenous neurotransmitter. Pharmacokinetics, mechanisms of action in the periphery and central nervous system, clinical uses and adverse effects are also reviewed...
September 2016: Brain Research Bulletin
https://www.readbyqxmd.com/read/27111702/antidepressive-and-anxiolytic-effects-of-ayahuasca-a-systematic-literature-review-of-animal-and-human-studies
#16
Rafael G Dos Santos, Flávia L Osório, José Alexandre S Crippa, Jaime E C Hallak
OBJECTIVE: To conduct a systematic literature review of animal and human studies reporting anxiolytic or antidepressive effects of ayahuasca or some of its isolated alkaloids (dimethyltryptamine, harmine, tetrahydroharmine, and harmaline). METHODS: Papers published until 3 April 2015 were retrieved from the PubMed, LILACS and SciELO databases following a comprehensive search strategy and using a predetermined set of criteria for article selection. RESULTS: Five hundred and fourteen studies were identified, of which 21 met the established criteria...
March 2016: Revista Brasileira de Psiquiatria
https://www.readbyqxmd.com/read/27067625/novel-psychopharmacological-therapies-for-psychiatric-disorders-psilocybin-and-mdma
#17
REVIEW
Michael C Mithoefer, Charles S Grob, Timothy D Brewerton
4-phosphorloxy-N,N-dimethyltryptamine (psilocybin) and methylenedioxymethamfetamine (MDMA), best known for their illegal use as psychedelic drugs, are showing promise as therapeutics in a resurgence of clinical research during the past 10 years. Psilocybin is being tested for alcoholism, smoking cessation, and in patients with advanced cancer with anxiety. MDMA is showing encouraging results as a treatment for refractory post-traumatic stress disorder, social anxiety in autistic adults, and anxiety associated with a life-threatening illness...
May 2016: Lancet Psychiatry
https://www.readbyqxmd.com/read/27039035/inhibition-of-alpha-oscillations-through-serotonin-2a-receptor-activation-underlies-the-visual-effects-of-ayahuasca-in-humans
#18
Marta Valle, Ana Elda Maqueda, Mireia Rabella, Aina Rodríguez-Pujadas, Rosa Maria Antonijoan, Sergio Romero, Joan Francesc Alonso, Miquel Àngel Mañanas, Steven Barker, Pablo Friedlander, Amanda Feilding, Jordi Riba
Ayahuasca is an Amazonian psychotropic plant tea typically obtained from two plants, Banisteriopsis caapi and Psychotria viridis. It contains the psychedelic 5-HT2A and sigma-1 agonist N,N-dimethyltryptamine (DMT) plus β-carboline alkaloids with monoamine-oxidase (MAO)-inhibiting properties. Although the psychoactive effects of ayahuasca have commonly been attributed solely to agonism at the 5-HT2A receptor, the molecular target of classical psychedelics, this has not been tested experimentally. Here we wished to study the contribution of the 5-HT2A receptor to the neurophysiological and psychological effects of ayahuasca in humans...
July 2016: European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology
https://www.readbyqxmd.com/read/26977821/modification-of-5-methoxy-n-n-dimethyltryptamine-induced-hyperactivity-by-monoamine-oxidase-a-inhibitor-harmaline-in-mice-and-the-underlying-serotonergic-mechanisms
#19
Xi-Ling Jiang, Hong-Wu Shen, Ai-Ming Yu
BACKGROUND: 5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) and harmaline are indolealkylamine (IAA) drugs often abused together. Our recent studies have revealed the significant effects of co-administered harmaline, a monoamine oxidase inhibitor (MAOI), on 5-MeO-DMT pharmacokinetics and thermoregulation. This study was to delineate the impact of harmaline and 5-MeO-DMT on home-cage activity in mouse models, as well as the contribution of serotonin (5-HT) receptors. METHODS: Home-cage activities of individual animals were monitored automatically in the home cages following implantation of telemetry transmitters and administration of various doses of IAA drugs and 5-HT receptor antagonists...
June 2016: Pharmacological Reports: PR
https://www.readbyqxmd.com/read/26976063/ayahuasca-pharmacology-neuroscience-and-therapeutic-potential
#20
Elisabet Domínguez-Clavé, Joaquim Soler, Matilde Elices, Juan C Pascual, Enrique Álvarez, Mario de la Fuente Revenga, Pablo Friedlander, Amanda Feilding, Jordi Riba
Ayahuasca is the Quechua name for a tea obtained from the vine Banisteriopsis caapi, and used for ritual purposes by the indigenous populations of the Amazon. The use of a variation of the tea that combines B. caapi with the leaves of the shrub Psychotria viridis has experienced unprecedented expansion worldwide for its psychotropic properties. This preparation contains the psychedelic 5-HT2A receptor agonist N,N-dimethyltryptamine (DMT) from P. viridis, plus β-carboline alkaloids with monoamine-oxidase-inhibiting properties from B...
March 11, 2016: Brain Research Bulletin
keyword
keyword
77712
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"